Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 38,280 | 41,131 | 46,746 | 44,447 | 51,767 |
| Operating Income | -38,280 | -41,131 | -46,746 | -44,447 | -51,767 |
| Other Income | 6,046 | 4,199 | 3,472 | 2,236 | 2,821 |
| Pre-tax Income | -32,234 | -36,932 | -43,274 | -42,211 | -48,946 |
| Net Income Continuous | -32,234 | -36,932 | -43,274 | -42,211 | -48,946 |
| Net Income | $-32,234 | $-36,932 | $-43,274 | $-42,211 | $-48,946 |
| EPS Basic Total Ops | -0.32 | -0.52 | -0.66 | -0.79 | -1.00 |
| EPS Basic Continuous Ops | -0.31 | -0.52 | -0.66 | -0.79 | -1.00 |
| EPS Diluted Total Ops | -0.32 | -0.52 | -0.66 | -0.79 | -1.00 |
| EPS Diluted Continuous Ops | -0.31 | -0.52 | -0.66 | -0.79 | -1.00 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.52 | -0.66 | -0.79 | -0.98 |
| EBITDA(a) | $-38,267 | $-41,116 | $-46,730 | $-44,432 | $-51,752 |